Skip to main content
Drug Design, Development and Therapy logoLink to Drug Design, Development and Therapy
. 2021 Jan 27;15:349. doi: 10.2147/DDDT.S302182

Therapeutic Effects of Modified Gengnianchun Formula on Stress-Induced Diminished Ovarian Reserve Based on Experimental Approaches and Network Pharmacology [Erratum]

PMCID: PMC7850433  PMID: 33536748

Gao L, Zhang Y, Xu H, Zhao F, Wang W. Drug Des Devel Ther. 2020;14:4975–4992

The authors have advised that there was an error in the author list on page 4975 which was introduced by the Editorial staff during the publication process.

The correct author list and affiliations are as follows:

Lingyun Gao1,2,*

Yang Zhang1,2,*

Huangfang Xu2

Fangui Zhao2,3

Wenjun Wang1,2

1Department of Integrated Traditional Chinese Medicine and Western Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China; 2Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, People’s Republic of China; 3Department of Ultrasound Diagnosis, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China

*These authors contributed equally to this work

There was also an error on page 4990. Acknowledgment section, the acknowledgment “Lingyun Gao and Yang Zhang are joint first authors” was not included by Editorial staff.


Articles from Drug Design, Development and Therapy are provided here courtesy of Dove Press

RESOURCES